-
公开(公告)号:EP2205548A1
公开(公告)日:2010-07-14
申请号:EP08837085.3
申请日:2008-10-03
申请人: Amgen, Inc
发明人: KIM, Yong-Jae , BROWN, Sean, P. , CAO, Qiong , DRANSFIELD, Paul, J. , DU, Xiaohui , HOUZE, Jonathan , JIAO, Xian Yun , KOHN, Todd, J. , LAI, Sujen , LI, An-Rong , LIN, Daniel , LUO, Jian , MEDINA, Julio, C. , REAGAN, Jeffrey, D. , PATTAROPONG, Vatee , SCHWARZ, Margrit , SHEN, Wang , SU, Yongli , SWAMINATH, Gayathri , VIMOLRATANA, Marc , WANG, Xiang , XIONG, Yumei , YANG, Li , YU, Ming , ZHANG, Jie , ZHU, Liusheng , FU, Zice , LIU, Jiwen , WANG, Yingcai
IPC分类号: C07C59/68 , C07C217/54 , C07C323/19 , C07D213/64 , A61K31/192 , A61K31/4415 , A61P3/10
CPC分类号: C07C323/62 , C07C59/68 , C07C59/72 , C07C217/54 , C07C217/62 , C07C317/22 , C07C323/19 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/10 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/42 , C07C2603/74 , C07D213/64 , C07D309/12
摘要: The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.
摘要翻译: 本发明提供了可用于例如治疗受试者代谢紊乱的化合物。 这些化合物具有通式I:其中本文提供变量的定义。 本发明还提供了组合物,其包括化合物在制备药物和用于治疗代谢性疾病如II型糖尿病中的使用方法。
-
2.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE ALS MDM2-HEMMER ZUR KREBSBEHANDLUNG公开(公告)号:EP2576510B1
公开(公告)日:2015-04-29
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
-
3.PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER 有权
标题翻译: PIPERIDINONDERIVATE AS MDM2抑制剂用于癌症治疗公开(公告)号:EP2576510A1
公开(公告)日:2013-04-10
申请号:EP11726581.9
申请日:2011-06-03
申请人: Amgen Inc.
发明人: BARTBERGER, Michael David , GONZALEZ BUENROSTRO, Ana , BECK, Hilary Plake , CHEN, Xiaoqi , CONNORS, Richard Victor , DEIGNAN, Jeffrey , DUQUETTE, Jason , EKSTEROWICZ, John , FISHER, Benjamin , FOX, Brian Matthew , FU, Jiasheng , FU, Zice , GONZALEZ LOPEZ DE TURISO, Felix , GRIBBLE, JR., Michael William , GUSTIN, Darin James , HEATH, Julie Anne , HUANG, Xin , JIAO, Xianyun , JOHNSON, Michael , KAYSER, Frank , KOPECKY, David John , LAI, Sujen , LI, Yihong , LI, Zhihong , LIU, Jiwen , LOW, Jonathan Dante , LUCAS, Brian Stuart , MA, Zhihua , MCGEE, Lawrence , MCINTOSH, Joel , MCMINN, Dustin , MEDINA, Julio Cesar , MIHALIC, Jeffrey Thomas , OLSON, Steven Howard , REW, Yosup , ROVETO, Philip Marley , SUN, Daqing , WANG, Xiaodong , WANG, Yingcai , YAN, Xuelei , YU, Ming , ZHU, Jiang
IPC分类号: C07D211/40 , C07D401/04 , C07D401/06 , C07D407/04 , C07D407/06 , C07D409/04 , C07D413/06 , C07D417/06 , C07D471/20 , C07D279/02 , C07D401/12 , C07D498/08 , C07D498/20 , A61K31/4412 , A61P35/00
CPC分类号: C07D211/76 , C07D221/20 , C07D279/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/12 , C07D407/04 , C07D407/06 , C07D409/04 , C07D409/12 , C07D413/06 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/10 , C07D491/08 , C07D491/153 , C07D498/08 , C07D498/14 , C07D498/20
摘要: The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
-
-